{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:50:27Z","timestamp":1789768227371,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","award":["2161"],"award-info":[{"award-number":["2161"]}],"id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","award":["2189"],"award-info":[{"award-number":["2189"]}],"id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["3-170649"],"award-info":[{"award-number":["3-170649"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI157155"],"award-info":[{"award-number":["R01 AI157155"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["HR001117S0019"],"award-info":[{"award-number":["HR001117S0019"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["P01AI120943"],"award-info":[{"award-number":["P01AI120943"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["R01AI107056"],"award-info":[{"award-number":["R01AI107056"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["R01AI123926"],"award-info":[{"award-number":["R01AI123926"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jmb.2021.167177","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T04:46:12Z","timestamp":1627447572000},"page":"167177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations"],"prefix":"10.1016","volume":"433","author":[{"given":"Shane","family":"Miersch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Saberianfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart","family":"Ustav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brett Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Blazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alevtina","family":"Pavlenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryna","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Garcia Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryasree","family":"Subramania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Ploder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safder","family":"Ganaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy W.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Matusali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Colavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Capobianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaya K.","family":"Amarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachdev S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2021.167177_b0005","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 \u2014 Preliminary Report","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2021.167177_b0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2021.167177_b0015","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.jmb.2021.167177_b0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0025","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2021.167177_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jmb.2021.167177_b0035","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA \u2013 J. Am. Med. Assoc."},{"key":"10.1016\/j.jmb.2021.167177_b0040","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.2000583","article-title":"A potently neutralizing antibody protects mice against SARS-CoV-2 infection","volume":"205","author":"Alsoussi","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2021.167177_b0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0055","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0060","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0065","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"Ter Meulen","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2021.167177_b0070","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0075","article-title":"SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography","author":"Klein","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2021.167177_b0080","first-page":"1","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","author":"Ke","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2021.167177_b0090","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jmb.2021.167177_b0095","unstructured":"D. Pinto, Y.-J. Park, M. Beltramello, A.C. Walls, M.A. Tortorici, S. Bianchi, S. Jaconi, K. Culap, F. Zatta, A. De Marco, A. Peter, B. Guarino, R. Spreafico, E. Cameroni, J.B. Case, R.E. Chen, C. Havenar-Daughton, G. Snell, A. Telenti, H.W. Virgin, A. Lanzavecchia, M.S. Diamond, K. Fink, D. Veesler, D. Corti, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, (n.d.). https:\/\/doi.org\/10.1038\/s41586-020."},{"key":"10.1016\/j.jmb.2021.167177_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2021.167177_b0105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167177_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107918","article-title":"Human-IgG-neutralizing monoclonal antibodies block the SARS-CoV-2 infection","volume":"32","author":"Wan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2021.167177_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18159-4","article-title":"A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes","volume":"11","author":"Noy-Porat","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2021.167177_b0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.abc7424","article-title":"Broad neutralization of SARS-related viruses by human monoclonal antibodies","volume":"369","author":"Wec","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167177_b0125","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","article-title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease","volume":"17","author":"Cobleigh","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jmb.2021.167177_b0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jmb.2012.11.037","article-title":"CDR-H3 diversity is not required for antigen recognition by synthetic antibodies","volume":"425","author":"Persson","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167177_b0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09385","article-title":"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation","volume":"467","author":"Mouquet","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0140","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0150","article-title":"Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition","author":"Greaney","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2021.167177_b0155","first-page":"1","article-title":"Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0160","doi-asserted-by":"crossref","unstructured":"E. Volz, S. Mishra, M. Chand, J.C. Barrett, R. Johnson, S. Hopkins, A. Gandy, A. Rambaut, N.M. Ferguson, Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data, MedRxiv. (2021) 2020.12.30.20249034. https:\/\/doi.org\/10.1101\/2020.12.30.20249034.","DOI":"10.1101\/2020.12.30.20249034"},{"key":"10.1016\/j.jmb.2021.167177_b0165","doi-asserted-by":"crossref","unstructured":"N.R. Faria, T.A. Mellan, C. Whittaker, I.M. Claro, D. da S. Candido, S. Mishra, M.A.E. Crispim, F.C. Sales, I. Hawryluk, J.T. McCrone, R.J.G. Hulswit, L.A.M. Franco, M.S. Ramundo, J.G. de Jesus, P.S. Andrade, T.M. Coletti, G.M. Ferreira, C.A.M. Silva, E.R. Manuli, R.H.M. Pereira, P.S. Peixoto, M.U. Kraemer, N. Gaburo, C. da C. Camilo, H. Hoeltgebaum, W.M. Souza, E.C. Rocha, L.M. de Souza, M.C. de Pinho, L.J.T. Araujo, F.S. V Malta, A.B. de Lima, J. do P. Silva, D.A.G. Zauli, A.C. de S. Ferreira, R.P. Schnekenberg, D.J. Laydon, P.G.T. Walker, H.M. Schl\u00fcter, A.L.P. Dos Santos, M.S. Vidal, V.S. Del Caro, R.M.F. Filho, H.M. Dos Santos, R.S. Aguiar, J.L.P. Modena, B. Nelson, J.A. Hay, M. Monod, X. Miscouridou, H. Coupland, R. Sonabend, M. Vollmer, A. Gandy, M.A. Suchard, T.A. Bowden, S.L.K. Pond, C.-H. Wu, O. Ratmann, N.M. Ferguson, C. Dye, N.J. Loman, P. Lemey, A. Rambaut, N.A. Fraiji, M. do P.S.S. Carvalho, O.G. Pybus, S. Flaxman, S. Bhatt, E.C. Sabino, Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil., MedRxiv\u202f: The Preprint Server for Health Sciences. (2021) 2021.02.26.21252554. https:\/\/doi.org\/10.1101\/2021.02.26.21252554.","DOI":"10.1126\/science.abh2644"},{"key":"10.1016\/j.jmb.2021.167177_b0170","first-page":"1","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2021.167177_b0175","doi-asserted-by":"crossref","unstructured":"P. Wang, L. Liu, S. Iketani, Y. Luo, Y. Guo, M. Wang, J. Yu, B. Zhang, P.D. Kwong, B.S. Graham, J.R. Mascola, J.Y. Chang, M.T. Yin, M. Sobieszczyk, C.A. Kyratsous, L. Shapiro, Z. Sheng, M.S. Nair, Y. Huang, D.D. Ho, Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization., BioRxiv\u202f: The Preprint Server for Biology. (2021). https:\/\/doi.org\/10.1101\/2021.01.25.428137.","DOI":"10.1038\/s41586-021-03398-2"},{"key":"10.1016\/j.jmb.2021.167177_b0180","doi-asserted-by":"crossref","unstructured":"B.E. Jones, P.L. Brown-Augsburger, K.S. Corbett, K. Westendorf, J. Davies, T.P. Cujec, C.M. Wiethoff, J.L. Blackbourne, B.A. Heinz, D. Foster, R.E. Higgs, D. Balasubramaniam, L. Wang, R. Bidshahri, L. Kraft, Y. Hwang, S. \u017dentelis, K.R. Jepson, R. Goya, M.A. Smith, D.W. Collins, S.J. Hinshaw, S.A. Tycho, D. Pellacani, P. Xiang, K. Muthuraman, S. Sobhanifar, M.H. Piper, F.J. Triana, J. Hendle, A. Pustilnik, A.C. Adams, S.J. Berens, R.S. Baric, D.R. Martinez, R.W. Cross, T.W. Geisbert, V. Borisevich, O. Abiona, H.M. Belli, M. De Vries, A. Mohamed, M. Dittmann, M. Samanovic, M.J. Mulligan, J.A. Goldsmith, C.-L. Hsieh, N. V Johnson, D. Wrapp, J.S. Mclellan, B.C. Barnhart, B.S. Graham, J.R. Mascola, C.L. Hansen, E. Falconer, Title: LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection, (n.d.). https:\/\/doi.org\/10.1101\/2020.09.30.318972.","DOI":"10.1101\/2020.09.30.318972"},{"key":"10.1016\/j.jmb.2021.167177_b0185","first-page":"eabc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167177_b0190","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167177_b0195","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2021.167177_b0200","first-page":"eabe3255","article-title":"An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike","author":"Schoof","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167177_b0205","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar SARS-CoV-2 miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167177_b0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-021-00405-z","article-title":"Trastuzumab immunogenicity development in patients\u2019 sera and in laboratory animals","volume":"22","author":"Kilany","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jmb.2021.167177_b0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bsheal.2020.01.003","article-title":"A strategy to prevent future epidemics similar to the 2019-nCoV outbreak","volume":"2","author":"Daszak","year":"2020","journal-title":"Biosafety and Health"},{"key":"10.1016\/j.jmb.2021.167177_b0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virusres.2007.03.012","article-title":"A review of studies on animal reservoirs of the SARS coronavirus","volume":"133","author":"Shi","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.jmb.2021.167177_b0225","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1074\/mcp.O115.052209","article-title":"A high through-put platform for recombinant antibodies to folded proteins","volume":"14","author":"Hornsby","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jmb.2021.167177_b0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains","volume":"27","author":"Lefranc","year":"2003","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.jmb.2021.167177_b0235","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1073\/pnas.1218620110","article-title":"Simple piggyBac transposon-based mammalian cell expression system for inducible protein production","volume":"110","author":"Li","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0240","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0969-2126(97)00233-5","article-title":"Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain","volume":"5","author":"Tao","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2021.167177_b0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-2272-7_12","article-title":"Site-specific biotinylation of purified proteins using BirA","volume":"1266","author":"Fairhead","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167177_b0250","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2021.167177_b0255","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acschembio.6b00990","article-title":"Structure-directed and tailored diversity synthetic antibody libraries yield novel anti-EGFR antagonists","volume":"12","author":"Miersch","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jmb.2021.167177_b0260","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1087057114557781","article-title":"High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody","volume":"20","author":"Niedziela-Majka","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jmb.2021.167177_b0265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2021.167177_b0270","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jmb.2021.167177_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)42829-8","article-title":"Primary structure of the streptomyces enzyme endo-@-N-acetylglucosaminidase H*","author":"Robbins","year":"1984","journal-title":"The J. Biol. Chem."},{"key":"10.1016\/j.jmb.2021.167177_b0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallographica. Section D, Biol. Crystallography"},{"key":"10.1016\/j.jmb.2021.167177_b0285","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jmb.2021.167177_b0290","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1039\/C9ME00020H","article-title":"Repertoire builder: High-throughput structural modeling of B and T cell receptors","volume":"4","author":"Schritt","year":"2019","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.jmb.2021.167177_b0295","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2021.167177_b0300","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2021.167177_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"Zhang","year":"2016","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jmb.2021.167177_b0310","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167177_b0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jsb.2015.08.007","article-title":"Alignment of cryo-EM movies of individual particles by optimization of image translations","volume":"192","author":"Rubinstein","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jmb.2021.167177_b0320","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"CryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jmb.2021.167177_b0325","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","article-title":"Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs","volume":"16","author":"Bepler","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jmb.2021.167177_b0330","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2021.167177_b0335","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera - A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmb.2021.167177_b0340","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: Model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2021.167177_b0345","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17219","article-title":"Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta","volume":"5","author":"Wang","year":"2016","journal-title":"ELife"},{"key":"10.1016\/j.jmb.2021.167177_b0350","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: Recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallographica Section D: Struct. Biol."},{"key":"10.1016\/j.jmb.2021.167177_b0355","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283621004101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283621004101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:22:14Z","timestamp":1762669334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283621004101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":71,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0022283621004101"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2021.167177","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.31.362848","asserted-by":"object"}]},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2021.167177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"167177"}}